
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
ESTRING® (estradiol)
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
ESTRING® Quick Finder
INDICATIONS AND USAGE
ESTRING is indicated for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause.
DOSAGE AND ADMINISTRATION
One ESTRING (estradiol vaginal system) is to be inserted as deeply as possible into the upper one-third of the vaginal vault. The ring is to remain in place continuously for three months, after...
CONTRAINDICATIONS
ESTRING is contraindicated in women with any of the following conditions:
- 1.
- Undiagnosed abnormal genital bleeding.
- 2.
- Known, suspected, or history of breast cancer. ...
WARNINGS
See BOXED WARNINGS
ESTRING is a vaginal administered product with low systemic absorption following continuous use for 3 months (see CLINICAL...
OVERDOSAGE
Overdosage of estrogen may cause nausea, vomiting, breast tenderness, abdominal pain, drowsiness and fatigue, and withdrawal bleeding may occur in women. Treatment of overdose consists of discontinuation of...
DESCRIPTION
ESTRING® (estradiol vaginal system) is a slightly opaque ring with a whitish core containing a drug reservoir of 2 mg estradiol. Estradiol, silicone polymers, barium sulfate and silicone...
CLINICAL PHARMACOLOGY
Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic...
CLINICAL STUDIES
Effects on vulvar and vaginal atrophy
Two controlled studies have demonstrated the efficacy of ESTRING (estradiol vaginal system) in the treatment of...
HOW SUPPLIED
Each ESTRING (estradiol vaginal system) contains 2 mg estradiol to deliver 7.5 mcg of estradiol per day over 90 days, and is individually packaged in a heat-sealed rectangular pouch consisting of three layers,...
PATIENT INFORMATION
ESTRING
(estradiol vaginal system)
Read this Patient Information before you start using ESTRING and each time you get a refill. There may be...
INSTRUCTIONS FOR USE
How should I use ESTRING?
ESTRING is a local estrogen therapy used after menopause to treat moderate to severe menopausal changes in and around the vagina. ESTRING...
Resources
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.
(800)-332-1088.